SC 13D/A 1 p24-3084sc13da.htm LUNA INNOVATIONS INCORPORATED
证券交易委员会  
华盛顿特区20549  
   
附表13D/A
 
根据1934年证券交易法
(第二次修正)*
 

luna innovations Incorporated

（发行人名称）
 

普通股，每股面值$0.001

（证券种类名称）
 

550351100

（CUSIP编号）
 
David J. Chanley
白帽资本合伙人有限合伙公司 狄翁星德大道48号
麦迪逊大道520号，33rd楼层
纽约州纽约市10022
(212) 257-5940
 
副本送往：
 

Eleazer Klein律师。

David A. Curtiss, Esq.

Schulte Roth & Zabel LLP
第919大道
纽约，NY 10022

(212) 756-2000

如果申报人此前已在表格13G上报告本表13D的对象所涉及的获取情况，并且 因为规则13d-l（e）、13d-l（f）或13d-l（g）的缘故而报告此表格，请打勾此框☐。
接收通知和通信的授权人）
 

2024年10月25日

（需要提交此声明的事件日期）。
 

 

如果申报人以前曾在13G表格上提交过一份声明，以报告与本13D表格所涉事务有关的收购，并且因为13d-1(e)、13d-1(f)或13d-1(g)规则而提交此表格，请勾选下面的框。 [ ]

 

(第1页，共14页)

______________________________

*除本表格中首次申报的证券种类外，对于具有可能改变先前披露信息的任何后续修改，本封面页的其余部分应当填写。

 

本封面其余部分所需的信息不应被视为1934年证券交易法第18条的""文件"目的（"行动）或其他 不受该法规定的任何责任，但应遵守该法的所有其他规定（但请参阅附注）。

 

CUSIP编号 550351100附表13D/A页面 2 第14页

 

1

报告人名称

白帽闪电机会有限合伙

2 如果是一组的成员，请检查适当的框（见说明书）

(a) ¨

(b) x

3 仅供SEC使用
4

所有基金类型的资金来源

未知

5 如果根据2(d)或2(e)项目需要披露法律诉讼，请勾选选框。 ¨
6

公民身份或组织地点

特拉华州。

持有的受益股份数量
股份
有益所有人
所有者
每个
报告
具有以下内容的人：		 7

唯一拥有投票权的股份数量

-0-

8

具有共同投票权

831,270股普通股，即可兑换成收益优先b系列转换优先股股份（如下列第4项所定义）（包括113,432股普通股，即可兑换成一项或多项后续发行的b系列转换优先股股份（如下列第4项所定义）

9

具有唯一处理权

-0-

10

具有共同处理权

831,270股普通股，即可兑换成收益优先b系列转换优先股股份（包括113,432股普通股，即可兑换成一项或多项后续发行的b系列转换优先股股份）

11

每个人拥有的股票总数

在转换为普通股的情况下，发行831,270股普通股（包括在一个或多个后续发行中可能发行的113,432股普通股）*

12 如果第11行的聚合金额排除某些股票，请勾选选框。 ¨
13

第（11）列金额所代表的类别所占的百分比。

2.3%*

14

报告人类型

PN

         

 

*本报告中所报告的b类可转换优先股股份的转换受到区块者的限制（如下文第4项所定义）。行(8)、(10)和(11)中普通股股份数量及比例

第四行（13）反映了本封面上报告的B系列可转换优先股的全部转换，然而，在任何特定时间转换此类B系列可转换优先股的能力受到阻碍者的约束，该阻碍者适用于报告人的受益所有权总额。

 

CUSIP编号 550351100附表13D/A页面 3 第14页

 

1

报告人名称

WH Lightning GP有限责任公司

2 如果是一组的成员，请检查适当的框（见说明书）

(a) ¨

(b) x

3 仅供SEC使用
4

所有基金类型的资金来源

AF

5 如果根据2(d)或2(e)项目需要披露法律诉讼，请勾选选框。 ¨
6

公民身份或组织地点

特拉华州。

持有的受益股份数量
股份
有益所有人
所有者
每个
报告
具有以下内容的人：		 7

唯一拥有投票权的股份数量

-0-

8

具有共同投票权

根据可转换的b系列可转换优先股股份转换为普通股份，发行831270股普通股（其中包括在一次或多次后续发行中可转换的b系列可转换优先股转换为普通股份的113432股）*

9

具有唯一处理权

-0-

10

具有共同处理权

根据可转换的b系列可转换优先股股份转换为普通股份，发行831270股普通股（其中包括在一次或多次后续发行中可转换的b系列可转换优先股转换为普通股份的113432股）*

11

每个人拥有的股票总数

831,270股普通股可转换而发行（包括113,432股普通股可转换而发行，其中包括在一个或多个后续发行中可转换的b系列可转换优先股股份）*

12 如果第11行的聚合金额排除某些股票，请勾选选框。 ¨
13

第（11）列金额所代表的类别所占的百分比。

2.3%*

14

报告人类型

OO

         

 

* 报告的b系列可转换优先股股份转换受到阻挡器的限制。第(8)、(10)和(11)行中的普通股股份数量和第(13)行中列出的百分比反映

关于本封面报告中系列B可转换优先股全部转换的报道，但是在任何给定时间内转换此类系列B可转换优先股的能力受到阻碍者的约束，该阻碍者适用于申报人的受益所有权总额。

 

CUSIP编号 550351100附表13D/A页面 4 第14页

 

1

报告人名称

白帽子战略合作伙伴II LP

2 如果是一组的成员，请检查适当的框（见说明书）

(a) ¨

(b) x

3 仅供SEC使用
4

所有基金类型的资金来源

未知

5 如果根据2(d)或2(e)项目需要披露法律诉讼，请勾选选框。 ¨
6

公民身份或组织地点

特拉华州。

持有的受益股份数量
股份
有益所有人
所有者
每个
报告
具有以下内容的人：		 7

唯一拥有投票权的股份数量

-0-

8

具有共同投票权

在转换为b系列可转换优先股份的股份后，可发行1,246,908股普通股（其中包括可转换优先股份转换后发行的170,149股普通股，可在一个或多个后续发行中发行）*

9

具有唯一处理权

-0-

10

具有共同处理权

在转换为b系列可转换优先股份的股份后，可发行1,246,908股普通股（其中包括可转换优先股份转换后发行的170,149股普通股，可在一个或多个后续发行中发行）*

11

每个人拥有的股票总数

在将b系列可转换优先股转换为普通股后，可发行1,246,908股普通股（其中包括一项或多项后续发行中可发行的b系列可转换优先股转换后的170,149股普通股）*

12 如果第11行的聚合金额排除某些股票，请勾选选框。 ¨
13

第（11）列金额所代表的类别所占的百分比。

3.5%*

14

报告人类型

PN

         

 

* 报告的b系列可转换优先股股份转换受到阻挡器的限制。第(8)、(10)和(11)行中的普通股股份数量和第(13)行中列出的百分比反映

关于本封面报告中系列B可转换优先股全部转换的报道，但是在任何给定时间内转换此类系列B可转换优先股的能力受到阻碍者的约束，该阻碍者适用于申报人的受益所有权总额。

 

CUSIP编号 550351100附表13D/A页面 5 第14页

 

1

举报人姓名

白帽 SP GP II LLC

2 如果是群组成员，请选中相应的复选框

(a) §

(b) x

3 仅限秒钟使用
4

资金来源

AF

5 如果根据第 2 (d) 或 2 (e) 项要求披露法律程序，请勾选复选框 §
6

公民身份或组织地点

特拉华州

的数量
股份
受益地
由... 拥有
每个
报告
有以下情况的人：		 7

唯一的投票权

-0-

8

共享投票权

转换后可发行1,246,908股普通股 b系列可转换优先股的股份（包括转换系列股份后可发行的170,149股普通股） b 可通过一次或多次后续发行发行的可转换优先股）*

9

唯一的处置力

-0-

10

共享的处置力

转换后可发行1,246,908股普通股 b系列可转换优先股的股份（包括转换系列股份后可发行的170,149股普通股） b 可通过一次或多次后续发行发行的可转换优先股）*

11

每个人实际拥有的总金额

转换后可发行1,246,908股普通股 b系列可转换优先股的股份（包括转换系列股份后可发行的170,149股普通股） b 可通过一次或多次后续发行发行的可转换优先股）*

12 检查第 (11) 行中的总金额是否不包括某些股票 §
13

用第 (11) 行中的金额表示的类别百分比

3.5%*

14

举报人类型

OO

         

 

* The conversion of the shares of Series B Convertible Preferred Stock reported herein is subject to the Blocker. The number of shares of Common Stock in rows (8), (10) and (11) and the percentage set forth in row (13) reflect the

conversion in full of the Series B Convertible Preferred Stock reported on this cover page, however, the ability to convert such Series B Convertible Preferred Stock at any given time is subject to the Blocker which applies to the beneficial ownership of the Reporting Persons in the aggregate.

 

CUSIP No. 550351100SCHEDULE 13D/APage 6 of 14 Pages

 

1

NAME OF REPORTING PERSON

White Hat Structured Opportunities LP

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) x

3 SEC USE ONLY
4

SOURCE OF FUNDS

WC

5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6

CITIZENSHIP OR PLACE OF ORGANIZATION

State of Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:		 7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

8,312,724 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock (including 1,134,328 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock issuable in one or more Subsequent Issuance(s))*

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

8,312,724 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock (including 1,134,328 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock issuable in one or more Subsequent Issuance(s))*

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

8,312,724 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock (including 1,134,328 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock issuable in one or more Subsequent Issuance(s))*

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

9.99%*

14

TYPE OF REPORTING PERSON

PN

         

 

*The conversion of the shares of Series B Convertible Preferred Stock reported herein is subject to the Blocker and the percentage set forth in row (13) gives effect to the Blocker. However, rows (8), (10) and (11) show the number

shares of Common Stock that would be issuable upon the conversion of the shares of Series B Convertible Preferred Stock in full and does not give effect to the Blocker. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to the Blocker, is less than the number of securities reported in rows (8), (10) and (11).

 

CUSIP No. 550351100SCHEDULE 13D/APage 7 of 14 Pages

 

1

NAME OF REPORTING PERSON

WHSO GP LLC

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) x

3 SEC USE ONLY
4

SOURCE OF FUNDS

AF

5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6

CITIZENSHIP OR PLACE OF ORGANIZATION

State of Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:		 7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

8,312,724 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock (including 1,134,328 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock issuable in one or more Subsequent Issuance(s))*

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

8,312,724 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock (including 1,134,328 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock issuable in one or more Subsequent Issuance(s))*

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

8,312,724 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock (including 1,134,328 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock issuable in one or more Subsequent Issuance(s))*

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

9.99%*

14

TYPE OF REPORTING PERSON

OO

         

 

*The conversion of shares of Series B Convertible Preferred Stock reported herein is subject to the Blocker and the percentage set forth in row (13) gives effect to the Blocker. However, rows (8), (10) and (11) show the number of shares of Common Stock that would be issuable upon the conversion of the shares of Series B Convertible Preferred

Stock in full and does not give effect to the Blocker. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to the Blocker, is less than the number of securities reported in rows (8), (10) and (11).

 

CUSIP No. 550351100SCHEDULE 13D/APage 8 of 14 Pages

 

1

NAME OF REPORTING PERSON

White Hat Capital Partners LP

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) x

3 SEC USE ONLY
4

SOURCE OF FUNDS

AF

5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6

CITIZENSHIP OR PLACE OF ORGANIZATION

State of Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:		 7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

10,390,902 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock (including 1,417,909 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock issuable in one or more Subsequent Issuance(s))*

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

10,390,902 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock (including 1,417,909 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock issuable in one or more Subsequent Issuance(s))*

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

10,390,902 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock (including 1,417,909 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock issuable in one or more Subsequent Issuance(s))*

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

9.99%*

14

TYPE OF REPORTING PERSON

PN

         

 

*The conversion of shares of Series B Convertible Preferred Stock reported herein is subject to the Blocker and the percentage set forth in row (13) gives effect to the Blocker. However, rows (8), (10) and (11) show the number of

shares of Common Stock that would be issuable upon the conversion of the shares of Series B Convertible Preferred Stock in full and does not give effect to the Blocker. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to the Blocker, is less than the number of securities reported in rows (8), (10) and (11).

 

CUSIP No. 550351100SCHEDULE 13D/APage 9 of 14 Pages

 

1

NAME OF REPORTING PERSON

David J. Chanley

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) x

3 SEC USE ONLY
4

SOURCE OF FUNDS

AF

5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6

CITIZENSHIP OR PLACE OF ORGANIZATION

United Stated of America

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:		 7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

10,390,902 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock (including 1,417,909 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock issuable in one or more Subsequent Issuance(s))*

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

10,390,902 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock (including 1,417,909 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock issuable in one or more Subsequent Issuance(s))*

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

10,390,902 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock (including 1,417,909 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock issuable in one or more Subsequent Issuance(s))*

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

9.99%*

14

TYPE OF REPORTING PERSON

IN

         

 

*The conversion of shares of Series B Convertible Preferred Stock reported herein is subject to the Blocker and the percentage set forth in row (13) gives effect to the Blocker. However, rows (8), (10) and (11) show the number of

shares of Common Stock that would be issuable upon the conversion of the shares of Series B Convertible Preferred Stock in full and does not give effect to the Blocker. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to the Blocker, is less than the number of securities reported in rows (8), (10) and (11).

 

CUSIP No. 550351100SCHEDULE 13D/APage 10 of 14 Pages

 

1

NAME OF REPORTING PERSON

Mark R. Quinlan

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) x

3 SEC USE ONLY
4

SOURCE OF FUNDS

AF

5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6

CITIZENSHIP OR PLACE OF ORGANIZATION

United States of America

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:		 7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

10,390,902 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock (including 1,417,909 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock issuable in one or more Subsequent Issuance(s))*

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

10,390,902 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock (including 1,417,909 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock issuable in one or more Subsequent Issuance(s))*

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

10,390,902 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock (including 1,417,909 shares of Common Stock issuable upon conversion of shares of Series B Convertible Preferred Stock issuable in one or more Subsequent Issuance(s))*

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

9.99%*

14

TYPE OF REPORTING PERSON

IN

         

 

*The conversion of shares of Series B Convertible Preferred Stock reported herein is subject to the Blocker and the percentage set forth in row (13) gives effect to the Blocker. However, rows (8), (10) and (11) show the number of

shares of Common Stock that would be issuable upon the conversion of the shares of Series B Convertible Preferred Stock in full and does not give effect to the Blocker. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to the Blocker, is less than the number of securities reported in rows (8), (10) and (11).

 

CUSIP No. 550351100SCHEDULE 13D/APage 11 of 14 Pages

The following constitutes Amendment No. 2 (“Amendment No. 2”) to the Schedule 13D filed by the undersigned with the Securities and Exchange Commission on December 27, 2023 (the “Original Schedule 13D”), as amended by Amendment No. 1 to the Original Schedule 13D filed by the undersigned with the Securities and Exchange Commission on July 23, 2024 (“Amendment No. 1,” and the Original Schedule 13D as amended by Amendment No. 1 and this Amendment No. 2, the “Schedule 13D”). This Amendment No. 2 amends the Schedule 13D as specifically set forth herein. Capitalized terms used herein and not otherwise defined in this Amendment No. 2 have the meanings set forth in the Schedule 13D.

 

Item 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
   
Item 3 of the Schedule 13D is hereby amended and supplemented to include the following:
 
  The White Hat Funds acquired the 3,000 Additional Shares (as defined below) reported herein in exchange for the Preferred Consent (as defined below) and an amount in cash equal to the par value thereof.  The White Hat Funds have the option to acquire in one or more additional closings an additional 9,500 shares of Series B Convertible Preferred Stock at $1,000 per share of Series B Convertible Preferred Stock. The source of the cash funds used to acquire the Additional Shares was the working capital of the White Hat Funds.

 

Item 4. PURPOSE OF TRANSACTION
   
Item 4 of the Schedule 13D is hereby amended and supplemented to include the following:
 
  First Amendment to Loan Agreement
   
  On October 25, 2024 (the “Closing Date”), certain funds affiliated with the Investment Manager (collectively, the “Lenders”) entered into that certain First Amendment (the “Loan Amendment”) to the Loan Agreement, with the Issuer, as borrower, Luna Technologies, Inc. and General Photonics Corp. as guarantors (together with the Issuer, the “Loan Parties”), and White Hat Lightning Opportunity LP, as agent (the “Agent”). The Loan Amendment provides for, among other things, the extension of certain incremental term facilities to the Issuer in an aggregate amount of $15,000,000 (the “Term Loans”), bringing the resulting total Term Loan commitment to $30,000,000, to provide funds for working capital and general corporate purposes of the Loan Parties.  The Loan Amendment provides that the Loan Agreement will mature on the earlier of (i) June 30, 2025, subject to possible extension if the Issuer meets certain milestones related to a Sale Transaction (as defined in the Loan Agreement), and (ii) the date on which a Sale Transaction closes.
   
  The Loan Amendment provides that the Loan Agreement will bear interest at a floating rate per annum equal to the Term SOFR (as defined in the Loan Amendment) plus a margin of 12%, with such interest payable monthly in cash in arrears, effective as of the Closing Date.
   

 

CUSIP No. 550351100SCHEDULE 13D/APage 12 of 14 Pages

 

  In connection with the Loan Amendment, on the Closing Date, the Loan Parties, Lenders, Agent and PNC Bank, National Association (“PNC”) entered into that certain First Amendment (the “Subordination Agreement Amendment” and, together with that certain Fifth Amendment to the Loan Agreement, dated as of December 1, 2020 between the Loan Parties and PNC, the Loan Amendment and the other ancillary transaction documents executed in connection with the Loan Amendment, the “Transaction Documents”) to the Subordination and Intercreditor Agreement, dated as of July 19, 2024, to, among other things, restate the relative rights and priority of PNC and the Agent.
   
  The foregoing description of the Loan Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Loan Amendment. For further information regarding the Loan Amendment, reference is made to the full text of the Loan Amendment, which has been filed as Exhibit 99.5 hereto and incorporated by reference herein.
   
  Private Placement of Series B Convertible Preferred Stock
   
  In connection with the execution of the Transaction Documents, on the Closing Date, the holders (the “Holders”) of the Issuer’s Series B Convertible Preferred Stock entered into that certain Letter Agreement (the “Letter Agreement”) with the Issuer pursuant to which, among other things, the Holders (i) provided consent to the Issuer’s entry into the Transaction Documents (the “Preferred Consent”) as required by the terms of the outstanding Series B Convertible Preferred Stock and (ii) agreed to exercise a portion of their right to purchase, on a pro rata basis, and the Issuer agreed to issue and sell, 3,000 shares of the Series B Convertible Preferred Stock (the “Additional Shares”) in exchange for the Preferred Consent and an amount in cash equal to the par value thereof, in accordance with the Subscription Agreement, as amended by the Letter Agreement.
   
  Following the transaction described herein, the Holders have the option to acquire in one or more additional closings an additional 9,500 shares of Series B Convertible Preferred Stock at $1,000 per share of Series B Convertible Preferred Stock.
   
  The foregoing description of the Letter Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Letter Agreement. For further information regarding the Letter Agreement, reference is made to the full text of the Letter Agreement, which has been filed as Exhibit 99.6 hereto and incorporated by reference herein.

 

 

CUSIP No. 550351100SCHEDULE 13D/APage 13 of 14 Pages

 

 

Item 5. INTEREST IN SECURITIES OF THE ISSUER
   
Items 5(a) and (b) of the Schedule 13D are hereby amended and restated in their entirety:
   
(a) See rows (11) and (13) of the cover pages to this Schedule 13D/A for the aggregate number of shares of Common Stock and percentages of shares of Common Stock beneficially owned by each of the Reporting Persons, which includes accumulated dividends through October 25, 2024.  The percentages used in this Schedule 13D/A are calculated based upon an aggregate of 34,697,019 shares of Common Stock outstanding as of December 20, 2023, as described in the Subscription Agreement, and assumes the conversion of the shares of Series B Convertible Preferred Stock held by the White Hat Funds, subject to the Blocker.
   
(b) See rows (7) through (10) of the cover pages to this Schedule 13D/A for the number of shares of Common Stock as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition, which includes accumulated dividends through October 25, 2024.

 

Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER
   
Item 6 of the Schedule 13D is hereby amended and supplemented to include the following:
   
  The information set forth in Item 4 of Amendment No. 2 is hereby incorporated by reference.

 

Item 7. MATERIAL TO BE FILED AS EXHIBITS
   
Item 7 of the Schedule 13D is hereby amended and supplemented to include the following:
   
Exhibit 99.5 First Amendment to Loan Agreement, dated as of October 25, 2024, by and among the Company, Luna Technologies, Inc., General Photonics Corp., White Hat Lightning Opportunity LP and certain funds affiliated with White Hat Capital Partners LP (incorporated by reference to Exhibit 10.2 of the Issuer’s Current Report on Form 8-K filed with the SEC on October 29, 2024).
   
Exhibit 99.6 Letter Agreement, dated as of October 25, 2024, by and among the Company and the Holders (incorporated by reference to Exhibit 10.3 of the Issuer’s Current Report on Form 8-K filed with the SEC on October 29, 2024).

 

 

 

CUSIP No. 550351100SCHEDULE 13D/APage 14 of 14 Pages

SIGNATURES

After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

DATE:  October 29, 2024 /s/ David J. Chanley
  DAVID J. CHANLEY, (i) individually, (ii) as Managing Member of:  (a) WH Lightning GP LLC, (x) for itself and (y) as General Partner of White Hat Lightning Opportunity LP, (b) White Hat SP GP II LLC, (x) for itself and (y) as General Partner of White Hat Strategic Partners II LP, (c) WHSO GP LLC, (x) for itself and (y) as General Partner of White Hat Structured Opportunities LP and (d) White Hat Capital Partners GP LLC, as General Partner of White Hat Capital Partners LP.
   
  /s/ Mark R. Quinlan
  MARK R. Quinlan, individually